A citation-based method for searching scientific literature

Ilana Cass, Rae Lynn Baldwin, Taz Varkey, Roxana Moslehi, Steven A Narod, Beth Y Karlan. Cancer 2003
Times Cited: 340



J Boyd, Y Sonoda, M G Federici, F Bogomolniy, E Rhei, D L Maresco, P E Saigo, L A Almadrones, R R Barakat, C L Brown, D S Chi, J P Curtin, E A Poynor, W J Hoskins. JAMA 2000
Times Cited: 379




List of shared articles



Times cited

Hereditary ovarian tumour syndromes: current update on genetics and imaging.
K P Shanbhogue, A S Prasad, F E Ucisik-Keser, V S Katabathina, A C Morani. Clin Radiol 2021
0

The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results from a Multicenter Cohort Study.
Angela Toss, Claudia Piombino, Elena Tenedini, Alessandra Bologna, Elisa Gasparini, Vittoria Tarantino, Maria Elisabetta Filieri, Luca Cottafavi, Filippo Giovanardi, Stefano Madrigali,[...]. Diagnostics (Basel) 2021
0

Five-year survival decreases over time in patients with BRCA-mutated ovarian cancer: a systemic review and meta-analysis.
Chen Nahshon, Ofra Barnett-Griness, Yakir Segev, Meirav Schmidt, Ludmila Ostrovsky, Ofer Lavie. Int J Gynecol Cancer 2020
1

Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer.
Yen Ting Shen, Lucy Wang, James C Evans, Christine Allen, Micheline Piquette-Miller. Int J Mol Sci 2019
0

Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study.
Wenhui Li, Di Shao, Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong, Fengming Guo, Zhe Wang, Mingzhi Ye. J Ovarian Res 2019
9


DNA damage repair in ovarian cancer: unlocking the heterogeneity.
Mary Ellen Gee, Zahra Faraahi, Aiste McCormick, Richard J Edmondson. J Ovarian Res 2018
18


Prognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cells.
Iwona K Rzepecka, Lukasz M Szafron, Agnieszka Stys, Anna Felisiak-Golabek, Agnieszka Podgorska, Agnieszka Timorek, Piotr Sobiczewski, Barbara Pienkowska-Grela, Mona El-Bahrawy, Jolanta Kupryjanczyk. Gynecol Oncol 2017
5

The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients.
Xiaohua Wu, Lingying Wu, Beihua Kong, Jihong Liu, Rutie Yin, Hao Wen, Ning Li, Hualei Bu, Yanling Feng, Qingli Li,[...]. Int J Gynecol Cancer 2017
30


BRCA1-mutated ovarian cancer with skin metastasis: a case report.
So Ra Oh, Jung-Woo Park, Hyun Young Kwon, Seo-Hee Rha. Obstet Gynecol Sci 2017
1

Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.
Ettore Capoluongo, Gillian Ellison, José Antonio López-Guerrero, Frederique Penault-Llorca, Marjolijn J L Ligtenberg, Susana Banerjee, Christian Singer, Eitan Friedman, Birgid Markiefka, Peter Schirmacher,[...]. Semin Oncol 2017
50

Prognostic factors in Polish patients with BRCA1-dependent ovarian cancer.
Wiktor Szatkowski, Paweł Blecharz, Jerzy W Mituś, Marek Jasiówka, Elżbieta Łuczyńska, Jerzy Jakubowicz, Tomasz Byrski. Hered Cancer Clin Pract 2016
0

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.
Renaud Sabatier, Elise Lavit, Jessica Moretta, Eric Lambaudie, Tetsuro Noguchi, François Eisinger, Elisabeth Cherau, Magali Provansal, Doriane Livon, Laetitia Rabayrol,[...]. Fam Cancer 2016
4

Ovarian cancer: Status of homologous recombination pathway as a predictor of drug response.
Nicolas De Picciotto, Wulfran Cacheux, Arnaud Roth, Pierre O Chappuis, S Intidhar Labidi-Galy. Crit Rev Oncol Hematol 2016
32


Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival.
Nicoletta Biglia, Paola Sgandurra, Valentina Elisabetta Bounous, Furio Maggiorotto, Eleonora Piva, Emanuele Pivetta, Riccardo Ponzone, Barbara Pasini. Ecancermedicalscience 2016
18

Synthetic lethality: the road to novel therapies for breast cancer.
Kiranjit K Dhillon, Ilirjana Bajrami, Toshiyasu Taniguchi, Christopher J Lord. Endocr Relat Cancer 2016
12

Treatment related toxicity in BRCA1-associated epithelial ovarian cancer - is DNA repairing impairment associated with more adverse events?
Agnieszka Badora-Rybicka, Magdalena Budryk, Elżbieta Nowara, Danuta Starzyczny-Słota. Contemp Oncol (Pozn) 2016
3

Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer.
Francisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, Julie M Cunningham, Brooke L Fridley, Melissa C Larson, Kathryn Alsop, Ed Dicks, Patricia Harrington, Susan J Ramus,[...]. Clin Cancer Res 2015
93



Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin.
Maryann Kwa, Susan Edwards, Andrea Downey, Elsa Reich, Robert Wallach, John Curtin, Franco Muggia. Ann Surg Oncol 2014
18

The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.
Arindam Paul, Soumen Paul. Front Biosci (Landmark Ed) 2014
68


[Hereditary ovarian carcinomas: clinico-biological features and treatment].
Anne Floquet, Eberhard Stoeckle, Sabrina Croce, Michel Longy, Gaétan Mc Grogan, Emmanuelle Barouk, Virginie Bubien, Delphine Garbay, Eglantine Joly, Frédéric Guyon. Bull Cancer 2014
3